A Neuren study of trofinetide, also known as NNZ-2566, for females with Rett Syndrome

Study Details

What does the study involve?

There is a target to enrol approximately 64 participants into the study.

Participants in the Rett study will:

  • Have study visits every 1-2 weeks for a total of 8 study visits.
  • Take study medication.
  • Have blood samples collected for laboratory testing.
  • Have Rett syndrome symptoms monitored.
  • Have heart activity monitored.


For more information on what the Rett-002 study involves, please visit the web page here.